BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 22382453)

  • 1. The efficacy evaluation of cryosurgery in pancreatic cancer patients with the expression of CD44v6, integrin-β1, CA199, and CEA.
    Zhou G; Chiu D; Qin D; Niu L; Cai J; He L; Huang W; Xu K
    Mol Biotechnol; 2012 Sep; 52(1):59-67. PubMed ID: 22382453
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of CD44v6 and integrin-β1 for the prognosis evaluation of pancreatic cancer patients after cryosurgery.
    Zhou G; Chiu D; Qin D; Niu L; Cai J; He L; Tan D; Xu K
    Diagn Pathol; 2013 Sep; 8():146. PubMed ID: 24004467
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum CA242, CA199, CA125, CEA, and TSGF are Biomarkers for the Efficacy and Prognosis of Cryoablation in Pancreatic Cancer Patients.
    Chen Y; Gao SG; Chen JM; Wang GP; Wang ZF; Zhou B; Jin CH; Yang YT; Feng XS
    Cell Biochem Biophys; 2015 Apr; 71(3):1287-91. PubMed ID: 25486903
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes in the expression of serum markers CA242, CA199, CA125, CEA, TNF-α and TSGF after cryosurgery in pancreatic cancer patients.
    Zhou G; Niu L; Chiu D; He L; Xu K
    Biotechnol Lett; 2012 Jul; 34(7):1235-41. PubMed ID: 22456901
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection and clinical significance of CD44v6 and integrin-β1 in pancreatic cancer patients using a triplex real-time RT-PCR assay.
    Zhou G; Chiu D; Qin D; Niu L; Cai J; He L; Huang W; Xu K
    Appl Biochem Biotechnol; 2012 Aug; 167(8):2257-68. PubMed ID: 22695923
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The establishment of the duplex real-time RT-PCR assay for the detection of CD44v6 in pancreatic cancer patients and clinical application.
    Zhou G; Chiu D; Qin D; Niu L; Cai J; He L; Huang W; Xu K
    Biotechnol Appl Biochem; 2012; 59(1):55-63. PubMed ID: 22332746
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The correlation between pre-operative serum tumor markers and lymph node metastasis in gastric cancer patients undergoing curative treatment.
    Li F; Li S; Wei L; Liang X; Zhang H; Liu J
    Biomarkers; 2013 Nov; 18(7):632-7. PubMed ID: 24066812
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic Value of Pretreatment Serum CA199 in Patients with Locally Advanced Rectal Cancer Treated with CRT Followed by TME with Normal Pretreatment Carcinoembryonic Antigen Levels.
    Huang D; Lin Q; Song J; Xu B
    Dig Surg; 2021; 38(1):24-29. PubMed ID: 33171467
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum CA724 has no diagnostic value for gastrointestinal tumors.
    Cao H; Zhu L; Li L; Wang W; Niu X
    Clin Exp Med; 2023 Oct; 23(6):2433-2442. PubMed ID: 36920593
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changing patterns of Serum CEA and CA199 for Evaluating the Response to First-line Chemotherapy in Patients with Advanced Gastric Adenocarcinoma.
    He B; Zhang HQ; Xiong SP; Lu S; Wan YY; Song RF
    Asian Pac J Cancer Prev; 2015; 16(8):3111-6. PubMed ID: 25921105
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Predictive value of preoperative detection of CEA and CA199 for prognosis in patients with stage II-III colorectal cancer].
    Chen L; Jiang B; Di J; Zhang C; Wang Z; Zhang N; Xing J; Cui M; Yang H; Yao Z; Su X
    Zhonghua Wei Chang Wai Ke Za Zhi; 2015 Sep; 18(9):914-9. PubMed ID: 26404690
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Carcinoembryonic antigen, carbohydrate antigen 199 and carbohydrate antigen 724 in gastric cancer and their relationship with clinical prognosis.
    Wang R; Zuo CL; Zhang R; Zhu LM
    World J Gastrointest Oncol; 2023 Aug; 15(8):1475-1485. PubMed ID: 37663935
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor markers for diagnosis, monitoring of recurrence and prognosis in patients with upper gastrointestinal tract cancer.
    Jing JX; Wang Y; Xu XQ; Sun T; Tian BG; Du LL; Zhao XW; Han CZ
    Asian Pac J Cancer Prev; 2014; 15(23):10267-72. PubMed ID: 25556459
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Value of multi-detector computed tomography combined with serum tumor markers in diagnosis, preoperative, and prognostic evaluation of pancreatic cancer.
    Su J; Wang Y; Shao H; You X; Li S
    World J Surg Oncol; 2022 Sep; 20(1):323. PubMed ID: 36175918
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined use of Serum miR-499a-5p and CA199 Increases the Diagnostic Sensitivity of Pancreatic Cancer.
    Shi Q; Feng K; Xia L; Wang C; Zhu J
    Clin Lab; 2019 Nov; 65(11):. PubMed ID: 31710444
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD44v/CD44s expression patterns are associated with the survival of pancreatic carcinoma patients.
    Li Z; Chen K; Jiang P; Zhang X; Li X; Li Z
    Diagn Pathol; 2014 Apr; 9():79. PubMed ID: 24708709
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Leukemia inhibitory factor is a novel biomarker to predict lymph node and distant metastasis in pancreatic cancer.
    Jiang W; Bai W; Li J; Liu J; Zhao K; Ren L
    Int J Cancer; 2021 Feb; 148(4):1006-1013. PubMed ID: 32914874
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of angiopoietin-1 on attachment and metastasis of human gastric cancer cell line BGC-823.
    Ou XL; Chen HJ; Sun WH; Hang C; Yang L; Guan YY; Yan F; Chen BA
    World J Gastroenterol; 2009 Nov; 15(43):5432-41. PubMed ID: 19916173
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of the diagnostic value of serum tumor markers, and fecal k-ras and p53 gene mutations for pancreatic cancer.
    Wu X; Lu XH; Xu T; Qian JM; Zhao P; Guo XZ; Yang XO; Jiang WJ
    Chin J Dig Dis; 2006; 7(3):170-4. PubMed ID: 16808798
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [mRNA expression of CK19 and CEA in peripheral blood of patients with breast cancer detected by real-time quantitative PCR].
    Zheng HY; Chen Q; Ye YB; Huang WW
    Zhonghua Yi Xue Za Zhi; 2008 Aug; 88(32):2267-70. PubMed ID: 19087676
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.